Eversept Partners’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Eversept Partners’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-199,963	Closed	-$456K	–	83
2024 Q2	$456K	Buy	+199,963	New	+$764K	0.03%	72

Eversept Partners's GTHX Position: Q3 2024 in Review

Eversept Partners sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 199,963 shares — an estimated $456K sold.

Eversept Partners first reported a position in GTHX in Q2 2024 and held it in 1 quarter. The position peaked at $456K in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Eversept Partners reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Eversept Partners sold 199,963 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $456K.
Eversept Partners first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Eversept Partners's G1 Therapeutics, Inc. Common Stock position peaked at $456K in Q2 2024.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Eversept Partners's 13F filing for Q3 2024, filed 14 Nov 2024.